2424
K. Modzelewski, S. Sowa
Paper
Synthesis
(SP)-Isopropyl(phenyl)phosphinous Acid-Borane L-Menthyl Ester
[(SP)-20d] (Table 5, entry 7), General Procedure C
(RP)-Methoxymethyl(phenyl)phosphinous Acid-Borane L-Menthyl
Ester [(RP)-20f] (Table 5, entry 12), General Procedure C
(RP)-19a (0.05 g, 0.149 mmol) reacted with i-PrI (0.373 mmol, 37.3
L) and NaH (6.3 mg, 0.156 mmol, 60% in mineral oil) according to
general procedure C to afford (SP)-20d (0.038 g, 0.119 mmol, 80%) as a
colorless oil.
(RP)-19a (0.05 g, 0.149 mmol) reacted with MOMCl (0.373 mmol, 27.8
L) and NaH (6.3 mg, 0.156 mmol, 60% in mineral oil) according to
general procedure C to afford (RP)-20f (0.021 g, 0.066 mmol, 44%) as a
colorless oil.
[]D25 –137.9 (c 1.25, CHCl3); Rf = 0.69 (hexane/EtOAc, 10:1).
[]D25 –105 (c 0.71, CHCl3); Rf = 0.52 (hexane/EtOAc, 10:1).
IR (ATR, thin film): 2958, 2934, 2864, 2385, 1453, 1110, 978, 794 cm–1
.
IR (ATR, thin film): 2954, 2626, 2868, 2378, 1437, 1111, 1009, 984,
694 cm–1
.
1H NMR (500 MHz, CDCl3): = 7.77–7.82 (m, 2 H), 7.49–7.53 (m, 1 H),
7.42–7.47 (m, 2 H), 3.99–4.06 (m, 1 H), 2.25–2.29 (m, 1 H), 2.18–2.29
(m, 1 H), 1.67–1.74 (m, 1 H), 1.56–1.67 (m, 2 H), 1.40–1.49 (m, 1 H),
1.25–1.39 (m, 2 H), 1.21 (dd, JH–H = 6.94 Hz, JH–H = 16.08 Hz, 3 H), 1.05–
1.12 (m, 1 H), 0.94 (dd, JH–H = 7.25 Hz, JH–H = 16.71 Hz, 3 H), 0.93 (d,
JH–H = 6.62 Hz, 3 H), 0.78–0.99 (m, 1 H), 0.75 (d, JH–H = 7.25 Hz, 3 H),
0.42–1.00 (br m, 3 H), 0.31 (d, JH–H = 6.94 Hz, 3 H).
1H NMR (500 MHz, CDCl3): = 7.73–7.88 (m, 2 H), 7.52–7.56 (m, 1 H),
7.46–7.50 (m, 2 H), 4.06–4.15 (m, 1 H), 3.89–3.98 (m, 2 H), 3.43 (s, 3
H), 2.22–2.28 (m, 1 H), 1.80–1.87 (m, 1 H), 1.59–1.69 (m, 2 H), 1.44–
1.52 (m, 1 H), 1.32–1.40 (m, 1 H), 1.12–1.19 (m, 1 H), 0.83–1.00 (m, 2
H), 0.95 (d, JH–H = 6.62 Hz, 3 H), 0.80 (d, JH–H = 6.94 Hz, 3 H), 0.51 (d,
JH–H = 6.94 Hz, 3 H), 0.47–1.18 (br m, 3 H).
4
4
13C NMR (125 MHz, CDCl3): = 131.6 (d, JP–C = 2.7 Hz, C), 131.5 (d,
13C NMR (125 MHz, CDCl3): = 132.0 (d, JP–C = 1.8 Hz, CH), 131.4 (d,
2JP–C = 10.9 Hz, CH), 131.3 (d, 1JP–C = 56.3 Hz, CH), 130.6 (d, 3JP–C = 10.0
2JP–C = 10.0 Hz, CH), 130.1 (d, JP–C = 63.8 Hz, C), 128.4 (d, JP–C = 10.0
Hz, CH), 80.2 (d, 2JP–C = 3.6 Hz, CHO), 70.3 (d, 1JP–C = 52.7 Hz, CH2), 61.8
(d, 3JP–C = 8.2 Hz, OCH3), 48.7 (d, JP–C = 4.4 Hz, CH), 43.4 (s, CH2), 34.1 (s,
CH2), 31.5 (s, CH), 25.5 (s, CH), 22.7 (s, CH2), 22.2 (s, CH3), 20.9 (s, CH3),
15.3 (s, CH3).
1
2
Hz, CH), 79.5 (d, 2JP–C = 4.5 Hz, CHO), 48.8 (d, JP–C = 5.5 Hz, CH), 43.6 (s,
1
CH2), 34.1 (s, CH2), 31.4 (s, CH), 29.6 (d, JP–C = 46.3 Hz, CH), 25.4 (s,
CH3), 22.6 (s, CH2), 22.1 (s, CH3), 20.9 (s, CH3), 16.1 (s, CH3), 15.6 (d,
2JP–C = 2.7 Hz, CH3), 15.0 (s, CH3).
31P NMR (202 MHz, CDCl3): = 117.14 (br m).
11B NMR (160 MHz, CDCl3): = –39.70 (br m).
31P NMR (202 MHz, CDCl3): = 104.62 (br m).
11B NMR (160 MHz, CDCl3): = –41.75 (br m).
MS (EI, 70 eV): m/z (%) = 170 (10), 169 (100), 168 (82) [M – BH3
10H12]+, 138 (12), 126 (54), 125 (68), 109 (21), 96 (10), 95 (48).
–
MS (EI, 70 eV): m/z (%) = 172 (11), 171 (74) [M – BH3 – C10H19]+, 141
(12), 140 (100), 138 (12), 134 (25), 125 (52), 121 (21), 95 (49).
C
HRMS (ESI): m/z [(M – BH3 + O) + Na]+ calcd for C19H31O2PNa:
345.1954; found: 345.1953.
Anal. Calcd for C18H32BO2P: C, 67.09; H, 10.01. Found: C, 67.15; H,
10.18.
Anal. Calcd for C19H34BOP: C, 71.26; H, 10.70. Found: C, 71.56; H,
10.80.
L-Menthoxy(phenyl)phosphine-Borane (21) (Table 5, entry 11),
General Procedure C33
(RP)-19a (0.05 g, 0.149 mmol) reacted with MOMCl (0.179 mmol, 17.9
L) and NaH (6 mg, 0.149 mmol, 60% in mineral oil) according to gen-
eral procedure C to afford an inseparable mixture of (RP)-20f (20%)
and 21 (11%) (yields determined from the 1H NMR spectrum).
(SP)-Allyl(phenyl)phosphinous Acid-Borane L-Menthyl Ester
[(SP)-20e] (Table 5, entry 10), General Procedure C
(RP)-19a (0.05 g, 0.149 mmol) reacted with allyl bromide (0.224
mmol, 19.3 L) and NaH (6.3 mg, 0.156 mmol, 60% in mineral oil) ac-
cording to general procedure C to afford (SP)-20e (0.038 g, 0.119
mmol, 80%) as a colorless oil.
Rf = 0.45 (hexane/EtOAc, 10:1).
1H NMR (500 MHz, CDCl3): = 7.78–7.83 (m, 2 H), 7.55–7.62 (m, 2 H),
7.51–7.55 (m, 1 H), 7.14 (dq, JP–H = 340.68 Hz, JH-H = 5.67 Hz, 1 H),
3.99–4.06 (m, 1 H), 2.03–2.10 (m, 1 H), 1.91–1.99 (m, 1 H), 1.59–1.66
(m, 2 H), 1.41–1.51 (m, 1 H), 1.31–1.40 (m, 1 H), 1.05–1.12 (m, 1 H),
0.83–1.00 (m, 2 H), 0.92 (d, JH–H = 6.62 Hz, 3 H), 0.85 (d, JH–H = 7.09 Hz,
3 H), 0.71 (d, JH–H = 6.94 Hz, 3 H), 0.50–1.15 (br m, 3 H).
[]D25 –105 (c 1.215, CHCl3); Rf = 0.67 (hexane/EtOAc, 6:1).
IR (ATR, thin film): 2926, 2866, 2379, 1437, 984, 772 cm–1
.
1H NMR (500 MHz, CDCl3): = 7.77–7.82 (m, 2 H), 7.50–7.54 (m, 1 H),
7.44–7.48 (m, 2 H), 5.62–5.74 (m, 1 H), 5.00–5.12 (m, 2 H), 4.01–4.10
(m, 1 H), 2.75–2.87 (m, 2 H), 2.20–2.27 (m, 1 H), 1.72–1.79 (m, 1 H),
1.57–1.67 (m, 2 H), 1.42–1.51 (m, 1 H), 1.26–1.35 (m, 1 H), 1.06–1.13
(m, 1 H), 0.82–0.97 (m, 2 H), 0.94 (d, JH–H = 6.31 Hz, 3 H), 0.77 (d, JH–H
6.94 Hz, 3 H), 0.51–1.13 (br m, 3 H), 0.44 (d, JH–H = 6.94 Hz, 3 H).
4
13C NMR (125 MHz, CDCl3): = 132.6 (d, JP–C = 1.8 Hz, CH), 132.0 (d,
2JP–C = 9.1 Hz, CH), 129.0 (d, 1JP–C = 66.3 Hz, C), 128.8 (d, 2JP–C = 10.0 Hz,
=
2
CH), 80.3 (d, JP–C = 6.4 Hz, CHO), 48.7 (d, JP–C = 5.5 Hz, CH), 42.0 (d,
JP–C = 1.8 Hz, CH2), 34.0 (s, CH2), 31.4 (s, CH), 25.5 (s, CH), 22.9 (s, CH2),
22.0 (s, CH3), 20.9 (s, CH3), 15.8 (s, CH3).
31P NMR (202 MHz, CDCl3): = 93.17 (br m).
MS (EI, 70 eV): m/z (%) = 126 (100) [M – BH3 – C10H19]+, 125 (52), 123
(13), 109 (33), 95 (12), 83 (31), 81 (21).
4
13C NMR (125 MHz, CDCl3): = 131.7 (d, JP–C = 2.7 Hz, CH), 131.6 (d,
2
3
1JP–C = 60.9 Hz, C), 131.0 (d, JP–C = 10.0 Hz, CH), 128.3 (d, JP–C = 10.0
Hz, CH), 127.8 (d, 2JP–C = 6.4 Hz, CH), 120.1 (d, 3JP–C = 10.9 Hz, CH2), 79.8
(d, 2JP–C = 3.6 Hz, CHO), 48.8 (d, JP–C = 5.5 Hz, CH), 43.7 (s, CH2), 38.1 (d,
1JP–C = 41.8 Hz, CH2), 34.1 (s, CH), 34.5 (s, CH), 25.5 (s, CH), 22.7 (s,
CH2), 22.2 (s, CH3), 20.9 (s, CH3), 15.2 (s, CH3).
31P NMR (202 MHz, CDCl3): = 107.82 (br m).
11B NMR (160 MHz, CDCl3): = –41.16 (br m).
(SP)-Isopropyl(phenyl)phosphinous Acid-Borane L-Menthyl Ester
[(SP)-20d] (Table 5, entry 8), General Procedure C
(RP)-19a (0.05 g, 0.149 mmol) reacted with i-PrBr (0.373 mmol, 34.9
L) and NaH (6.3 mg, 0.156 mmol, 60% in mineral oil) according to
general procedure C to afford (SP)-20d (0.021 g, 0.061 mmol, 45%).
MS (EI, 70 eV): m/z (%) = 168 (6), 167 (52), 166 (33) [M – BH3
10H19]+, 139 (12), 126 (6), 125 (100), 123 (12), 95 (49).
–
C
Anal. Calcd for C19H32BOP: C, 71.71; H, 10.14.; Found: C, 71.80; H,
10.26.
© 2020. Thieme. All rights reserved. Synthesis 2020, 52, 2410–2426